- How China Is Transforming the Biotech Industry: Brainstorm HealthHello and happy Monday, readers. Fortune sat down with Brad Loncar, a biotech investor who specializes in cancer immunotherapy, at our offices last week. Loncar runs both a U.S.-based index fund for cancer drug companies and, more recently, launched another one focused on China. It was a fascinating conversation that covered everything from the U.S. […]
- How This 20-Time Founder With Hundreds of Patents Got His StartThe terms “inventor” and “entrepreneur” seem wholly inadequate to describe Mir Imran, whose problem-solving approach to business has been key to his success.
- About Biopharma's Ridiculously Bad DayManufacturing issues, unexpected regulatory holdups, and other issues abound.
- A $43 Billion Biotech Now Has a Female CEOReshma Kewalramani is taking the reins at Vertex Pharmaceuticals from industry veteran Jeff Leiden.
- Moderna Had the Biggest Biotech IPO Ever. Here's What That Says About the Industry's FutureNasdaq's health care listings chief discusses the future of biotech IPOs after Moderna's historic feat.
- Controversial Startup Moderna Just Filed for the Biggest Biotech IPO EverThe unicorn is seeking to raise a staggering $500 million, despite having no products on the market.
- Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPOThe blockbuster public offering pegs Allogene's market value at more than $2 billion.
Skip to Content